Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed?
Peter F.J. Schulte, Selene Veerman, Egbert Bakker, Jan Bogers, Amy Jongkind, Dan Cohen
Topics & Concepts
ClozapineMedicineSchizophrenia (object-oriented programming)White blood cellLeukopeniaIntensive care medicinePediatricsPsychiatryInternal medicineToxicitySchizophrenia research and treatmentTryptophan and brain disordersBipolar Disorder and Treatment